Sweden· SE-20190410000012
Ducressa 1 mg/ml + 5 mg/ml Ögondroppar, lösning
A medicinal product containing dexamethasone + levofloxacin, registered in Sweden by Santen Oy.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Dexamethasone + Levofloxacin
- Manufacturer
- Santen Oy
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20190410000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethasone + levofloxacin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandDucressaMedezin Sp. z o.o.
- SpainDUCRESSA 1 MG/ML + 5 MG/ML COLIRIO EN SOLUCIONSanten Oy
- United KingdomDucressa 1mg/ml / 5mg/ml eye dropsSanten UK Ltd
- GermanyLevendexNtc Srl
- IcelandDucressaSanten Oy*
- NetherlandsDucressa 1 mg/ml / 5 mg/ml, oogdruppels, oplossingSanten Oy
- NorwayDucressaSanten Oy (1)
- IrelandDucressa 1 mg/ml + 5 mg/ml, eye drops, solutionSanten OY
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Ducressa
- Bulgaria · Ducressa
- Germany · Levendex
- Estonia · Ducressa
- Greece · Ducressa
- Croatia · Ducressa
- Ireland · Ducressa
- Italy · Ducressa, Leviosa
- Lithuania · Ducressa
- Netherlands · Ducressa
- Norway · Ducressa
- Romania · Ducressa Md
- Slovenia · Ducressa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78cf5d5e-021e-46ba-8c2f-a0f8fafd65aa GET /v1/drugs/78cf5d5e-021e-46ba-8c2f-a0f8fafd65aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20190410000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190410000012",
"product_doc_link": "https://docetp.mpa.se/LMF/Ducressa%20eye%20drops%2C%20solution%20SmPC_09001bee8103c04b.pdf"
}See everything about dexamethasone + levofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.